Osaic Holdings’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,000
Closed -$4.95K – 8162
2026
Q1
$4.95K Hold
1,000
– – ﹤0.01% 6688
2025
Q4
$4.67K Buy
1,000
+853
+580% +$3.86K ﹤0.01% 6747
2025
Q3
$700 Buy
147
+92
+167% +$316 ﹤0.01% 7464
2025
Q2
$182 Buy
+55
New +$164 ﹤0.01% 7519
2024
Q1
– Sell
-620
Closed -$2.89K – 7388
2023
Q4
$2.89K Buy
620
+402
+184% +$1.5K ﹤0.01% 6387
2023
Q3
$554 Buy
218
+25
+13% +$79 ﹤0.01% 6973
2023
Q2
$861 Buy
193
+2
+1% +$9 ﹤0.01% 6920
2023
Q1
$946 Sell
191
-135
-41% -$437 ﹤0.01% 6974
2022
Q4
$1K Sell
326
-137
-30% -$308 ﹤0.01% 6952
2022
Q3
$1K Buy
463
+44
+11% +$154 ﹤0.01% 7064
2022
Q2
$1K Buy
419
+62
+17% +$315 ﹤0.01% 7148
2022
Q1
$3K Sell
357
-60
-14% -$674 ﹤0.01% 6766
2021
Q4
$5K Sell
417
-214
-34% -$3.16K ﹤0.01% 6656
2021
Q3
$12K Buy
+631
New +$11.1K ﹤0.01% 6104

Other funds holding SOPH

Osaic Holdings's SOPH Position: Q2 2026 in Review

Osaic Holdings sold out of SOPHiA GENETICS (SOPH) in Q2 2026, closing a stake of 1,000 shares — an estimated $4.95K sold.

Osaic Holdings first reported a position in SOPH in Q3 2021 and held it in 14 quarters. The position peaked at $12K in Q3 2021. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Osaic Holdings reported no remaining SOPHiA GENETICS position as of Q2 2026 after selling out during the quarter.
  • Osaic Holdings sold 1,000 SOPHiA GENETICS shares in Q2 2026, an estimated $4.95K.
  • Osaic Holdings first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 14 quarters.
  • Osaic Holdings's SOPHiA GENETICS position peaked at $12K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.